{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T07:17:20Z","timestamp":1775200640508,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"joergbernards-Stiftung"},{"name":"K\u00f6ln Fortune"},{"name":"CECAD","award":["390661388"],"award-info":[{"award-number":["390661388"]}]},{"name":"Swedish Parkinson Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) are epigenetic modifications increasingly recognized for their roles in Parkinson\u2019s disease (PD). In this study, we profiled 5mC and 5hmC in blood samples from individuals with PD to explore their relevance to disease status and progression. We observed significantly reduced global 5hmC levels in peripheral blood mononuclear cells (PBMCs) from PD cases compared to controls. Using the Illumina EPIC BeadArray, we conducted genome-wide analyses of 5mC and 5hmC in a subset of PD cases and controls to explore methylation and hydroxymethylation patterns. We identified differentially methylated and hydroxymethylated positions and regions enriched within introns, with both types of regions showing a marked concentration near exon-intron junctions. Positional analysis relative to exon\u2013intron junctions revealed that proximal and distal regions mapped to partially different functional themes, suggesting that genomic context provides additional biological insight. Functional enrichment analyses also highlighted distinct biological roles for 5mC and 5hmC, with associated genes implicated in neurodevelopment, vascular remodeling, and neuroimmune signaling. Additionally, we demonstrate that global 5hmC levels, in combination with age and sex, are predictive of disease status, highlighting the potential of 5hmC as a blood-based biomarker for PD.<\/jats:p>","DOI":"10.1038\/s41531-026-01322-x","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T08:03:21Z","timestamp":1773993801000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Profiling of 5-hydroxymethylcytosine in blood reveals preferential enrichment at exon-intron junctions and predictive value for Parkinson\u2019s disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Philipp","family":"Antczak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lav","family":"Radosavljevi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Svenningsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00eblle","family":"R\u00fcegg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Be\u010danovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"1322_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nrg1831","volume":"7","author":"MJ Farrer","year":"2006","unstructured":"Farrer, M. J. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat. Rev. Genet. 7, 306\u2013318 (2006).","journal-title":"Nat. Rev. Genet."},{"key":"1322_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Prim. 3, 17013 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1322_CR3","doi-asserted-by":"publisher","DOI":"10.1100\/2012\/489830","volume":"2012","author":"F Coppede","year":"2012","unstructured":"Coppede, F. Genetics and epigenetics of Parkinson\u2019s disease. Sci. World J. 2012, 489830 (2012).","journal-title":"Sci. World J."},{"key":"1322_CR4","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091\u20131102 (2019).","journal-title":"Lancet Neurol."},{"key":"1322_CR5","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio, A. & Schwarzschild, M. A. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 15, 1257\u20131272 (2016).","journal-title":"Lancet Neurol."},{"key":"1322_CR6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1007\/s10654-011-9581-6","volume":"26","author":"K Wirdefeldt","year":"2011","unstructured":"Wirdefeldt, K., Adami, H. O., Cole, P., Trichopoulos, D. & Mandel, J. Epidemiology and etiology of Parkinson\u2019s disease: a review of the evidence. Eur. J. Epidemiol. 26, S1\u2013S58 (2011).","journal-title":"Eur. J. Epidemiol."},{"key":"1322_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrn.2017.46","volume":"18","author":"JY Hwang","year":"2017","unstructured":"Hwang, J. Y., Aromolaran, K. A. & Zukin, R. S. The emerging field of epigenetics in neurodegeneration and neuroprotection. Nat. Rev. Neurosci. 18, 347\u2013361 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"1322_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/npp.2012.112","volume":"38","author":"LD Moore","year":"2013","unstructured":"Moore, L. D., Le, T. & Fan, G. DNA methylation and its basic function. Neuropsychopharmacology 38, 23\u201338 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"1322_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg1655","volume":"6","author":"KD Robertson","year":"2005","unstructured":"Robertson, K. D. DNA methylation and human disease. Nat. Rev. Genet. 6, 597\u2013610 (2005).","journal-title":"Nat. Rev. Genet."},{"key":"1322_CR10","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930\u2013935 (2009).","journal-title":"Science"},{"key":"1322_CR11","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1126\/science.1210597","volume":"333","author":"S Ito","year":"2011","unstructured":"Ito, S. et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333, 1300\u20131303 (2011).","journal-title":"Science"},{"key":"1322_CR12","doi-asserted-by":"publisher","first-page":"e15367","DOI":"10.1371\/journal.pone.0015367","volume":"5","author":"D Globisch","year":"2010","unstructured":"Globisch, D. et al. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS ONE 5, e15367 (2010).","journal-title":"PLoS ONE"},{"key":"1322_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrg3080","volume":"13","author":"MR Branco","year":"2011","unstructured":"Branco, M. R., Ficz, G. & Reik, W. Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat. Rev. Genet. 13, 7\u201313 (2011).","journal-title":"Nat. Rev. Genet."},{"key":"1322_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41531-017-0007-3","volume":"3","author":"R Stoger","year":"2017","unstructured":"Stoger, R., Scaife, P. J., Shephard, F. & Chakrabarti, L. Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson\u2019s disease. NPJ Parkinsons Dis. 3, 6 (2017).","journal-title":"NPJ Parkinsons Dis."},{"key":"1322_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jchemneu.2018.12.005","volume":"96","author":"O Kaut","year":"2019","unstructured":"Kaut, O., Kuchelmeister, K., Moehl, C. & Wullner, U. 5-methylcytosine and 5-hydroxymethylcytosine in brains of patients with multiple system atrophy and patients with Parkinson\u2019s disease. J. Chem. Neuroanat. 96, 41\u201348 (2019).","journal-title":"J. Chem. Neuroanat."},{"key":"1322_CR16","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/s41593-020-0690-y","volume":"23","author":"LL Marshall","year":"2020","unstructured":"Marshall, L. L. et al. Epigenomic analysis of Parkinson\u2019s disease neurons identifies Tet2 loss as neuroprotective. Nat. Neurosci. 23, 1203\u20131214 (2020).","journal-title":"Nat. Neurosci."},{"key":"1322_CR17","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1093\/hmg\/ddac122","volume":"31","author":"S Min","year":"2022","unstructured":"Min, S. et al. Altered hydroxymethylome in the substantia nigra of Parkinson\u2019s disease. Hum. Mol. Genet. 31, 3494\u20133503 (2022).","journal-title":"Hum. Mol. Genet."},{"key":"1322_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fnmol.2017.00225","volume":"10","author":"E Miranda-Morales","year":"2017","unstructured":"Miranda-Morales, E. et al. Implications of DNA methylation in Parkinson\u2019s disease. Front. Mol. Neurosci. 10, 225 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"1322_CR19","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.4161\/epi.25865","volume":"8","author":"E Masliah","year":"2013","unstructured":"Masliah, E., Dumaop, W., Galasko, D. & Desplats, P. Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics 8, 1030\u20131038 (2013).","journal-title":"Epigenetics"},{"key":"1322_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10048-016-0497-x","volume":"18","author":"O Kaut","year":"2017","unstructured":"Kaut, O. et al. Epigenome-wide DNA methylation analysis in siblings and monozygotic twins discordant for sporadic Parkinson\u2019s disease revealed different epigenetic patterns in peripheral blood mononuclear cells. Neurogenetics 18, 7\u201322 (2017).","journal-title":"Neurogenetics"},{"key":"1322_CR21","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.3390\/ijms21062220","volume":"21","author":"O Martinez-Iglesias","year":"2020","unstructured":"Martinez-Iglesias, O. et al. DNA methylation in neurodegenerative and cerebrovascular disorders. Int J. Mol. Sci. 21, 2220 (2020).","journal-title":"Int J. Mol. Sci."},{"key":"1322_CR22","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1073\/pnas.1621218114","volume":"114","author":"H Green","year":"2017","unstructured":"Green, H. et al. Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson\u2019s disease. Proc. Natl. Acad. Sci. USA 114, 2735\u20132740 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1322_CR23","doi-asserted-by":"publisher","first-page":"212 e5","DOI":"10.1016\/j.neurobiolaging.2016.04.022","volume":"45","author":"C Ran","year":"2016","unstructured":"Ran, C. et al. Strong association between glucocerebrosidase mutations and Parkinson\u2019s disease in Sweden. Neurobiol. Aging 45, 212 e5\u2013212 e11 (2016).","journal-title":"Neurobiol. Aging"},{"key":"1322_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fnmol.2018.00043","volume":"11","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. Integrated genetic analysis of racial differences of common GBA variants in Parkinson\u2019s disease: a meta-analysis. Front. Mol. Neurosci. 11, 43 (2018).","journal-title":"Front. Mol. Neurosci."},{"key":"1322_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random forests. Mach. Learn. 45, 5\u201332 (2001).","journal-title":"Mach. Learn."},{"key":"1322_CR26","doi-asserted-by":"crossref","unstructured":"Cappellari, M. et al. The ATLAS3D project\u2014XX. Mass\u2013size and mass\u2013\u03c3 distributions of early-type galaxies: bulge fraction drives kinematics, mass-to-light ratio, molecular gas fraction and stellar initial mass function. Mon. Not. R Astron. Soc. 432, 1862\u20131893 (2013).","DOI":"10.1093\/mnras\/stt644"},{"key":"1322_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/15592294.2019.1588682","volume":"14","author":"A Henderson-Smith","year":"2019","unstructured":"Henderson-Smith, A. et al. DNA methylation changes associated with Parkinson\u2019s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood. Epigenetics 14, 365\u2013382 (2019).","journal-title":"Epigenetics"},{"key":"1322_CR28","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1017\/S0954422419000106","volume":"32","author":"LK Murray","year":"2019","unstructured":"Murray, L. K. & Jadavji, N. M. The role of one-carbon metabolism and homocysteine in Parkinson\u2019s disease onset, pathology and mechanisms. Nutr. Res. Rev. 32, 218\u2013230 (2019).","journal-title":"Nutr. Res. Rev."},{"key":"1322_CR29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3389\/fnins.2014.00397","volume":"8","author":"S Al-Mahdawi","year":"2014","unstructured":"Al-Mahdawi, S., Virmouni, S. A. & Pook, M. A. The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseases. Front. Neurosci. 8, 397 (2014).","journal-title":"Front. Neurosci."},{"key":"1322_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03172-8","volume":"11","author":"M Regoni","year":"2020","unstructured":"Regoni, M. et al. Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity. Cell Death Dis. 11, 963 (2020).","journal-title":"Cell Death Dis."},{"key":"1322_CR31","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1124\/pharmrev.122.000743","volume":"75","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Potassium channels in Parkinson\u2019s disease: potential roles in its pathogenesis and innovative molecular targets for treatment. Pharm. Rev. 75, 758\u2013788 (2023).","journal-title":"Pharm. Rev."},{"key":"1322_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2024.1359154","volume":"17","author":"J Jiang","year":"2024","unstructured":"Jiang, J. et al. Mutations in the postsynaptic density signaling hub TNIK disrupt PSD signaling in human models of neurodevelopmental disorders. Front. Mol. Neurosci. 17, 1359154 (2024).","journal-title":"Front. Mol. Neurosci."},{"key":"1322_CR33","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.3390\/cells9081887","volume":"9","author":"R Romano","year":"2020","unstructured":"Romano, R. & Bucci, C. Role of EGFR in the nervous system. Cells 9, 1887 (2020).","journal-title":"Cells"},{"key":"1322_CR34","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/j.1471-4159.2005.03073.x","volume":"93","author":"Y Iwakura","year":"2005","unstructured":"Iwakura, Y. et al. Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson\u2019s disease and its model: neurotrophic implication in nigrostriatal neurons. J. Neurochem. 93, 974\u2013983 (2005).","journal-title":"J. Neurochem."},{"key":"1322_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13210","volume":"19","author":"L Sun","year":"2020","unstructured":"Sun, L. et al. Attenuation of epigenetic regulator SMARCA4 and ERK-ETS signaling suppresses aging-related dopaminergic degeneration. Aging Cell 19, e13210 (2020).","journal-title":"Aging Cell"},{"key":"1322_CR36","doi-asserted-by":"publisher","first-page":"119465","DOI":"10.1016\/j.bbamcr.2023.119465","volume":"1870","author":"F Sardina","year":"2023","unstructured":"Sardina, F., Conte, A., Paladino, S., Pierantoni, G. M. & Rinaldo, C. HIPK2 in the physiology of nervous system and its implications in neurological disorders. Biochim. Biophys. Acta Mol. Cell Res. 1870, 119465 (2023).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"1322_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nn1816","volume":"10","author":"J Zhang","year":"2007","unstructured":"Zhang, J. et al. Essential function of HIPK2 in TGFbeta-dependent survival of midbrain dopamine neurons. Nat. Neurosci. 10, 77\u201386 (2007).","journal-title":"Nat. Neurosci."},{"key":"1322_CR38","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.3390\/genes12121975","volume":"12","author":"S Jo","year":"2021","unstructured":"Jo, S. et al. Microarray genotyping identifies new loci associated with dementia in Parkinson\u2019s disease. Genes 12, 1975 (2021).","journal-title":"Genes"},{"key":"1322_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63444-9","volume":"16","author":"DJ Vidyadhara","year":"2025","unstructured":"Vidyadhara, D. J. et al. Synaptic vesicle endocytosis deficits underlie cognitive dysfunction in mouse models of GBA-linked Parkinson\u2019s disease and dementia with Lewy bodies. Nat. Commun. 16, 8484 (2025).","journal-title":"Nat. Commun."},{"key":"1322_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-019-0436-5","volume":"12","author":"J Kelly","year":"2019","unstructured":"Kelly, J., Moyeed, R., Carroll, C., Albani, D. & Li, X. Gene expression meta-analysis of Parkinson\u2019s disease and its relationship with Alzheimer\u2019s disease. Mol. Brain 12, 16 (2019).","journal-title":"Mol. Brain"},{"key":"1322_CR41","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1750-3639.2012.00628.x","volume":"23","author":"J Guan","year":"2013","unstructured":"Guan, J. et al. Vascular degeneration in Parkinson\u2019s disease. Brain Pathol. 23, 154\u2013164 (2013).","journal-title":"Brain Pathol."},{"key":"1322_CR42","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/cells12071012","volume":"12","author":"S Isik","year":"2023","unstructured":"Isik, S., Yeman Kiyak, B., Akbayir, R., Seyhali, R. & Arpaci, T. Microglia mediated neuroinflammation in Parkinson\u2019s disease. Cells 12, 1012 (2023).","journal-title":"Cells"},{"key":"1322_CR43","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1021\/acschemneuro.5c00221","volume":"16","author":"EFD Nascimento","year":"2025","unstructured":"Nascimento, E. F. D. et al. Targeting the dectin-1 receptor in neuroinflammation: therapeutic implications for neuropsychiatric disorders. ACS Chem. Neurosci. 16, 3082\u20133095 (2025).","journal-title":"ACS Chem. Neurosci."},{"key":"1322_CR44","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1261\/rna.064865.117","volume":"24","author":"R Shayevitch","year":"2018","unstructured":"Shayevitch, R., Askayo, D., Keydar, I. & Ast, G. The importance of DNA methylation of exons on alternative splicing. RNA 24, 1351\u20131362 (2018).","journal-title":"RNA"},{"key":"1322_CR45","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/cr.2013.110","volume":"23","author":"AK Maunakea","year":"2013","unstructured":"Maunakea, A. K., Chepelev, I., Cui, K. & Zhao, K. Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition. Cell Res. 23, 1256\u20131269 (2013).","journal-title":"Cell Res."},{"key":"1322_CR46","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1101\/gr.143503.112","volume":"23","author":"S Gelfman","year":"2013","unstructured":"Gelfman, S., Cohen, N., Yearim, A. & Ast, G. DNA-methylation effect on cotranscriptional splicing is dependent on GC architecture of the exon-intron structure. Genome Res. 23, 789\u2013799 (2013).","journal-title":"Genome Res."},{"key":"1322_CR47","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.tig.2015.03.002","volume":"31","author":"G Lev Maor","year":"2015","unstructured":"Lev Maor, G., Yearim, A. & Ast, G. The alternative role of DNA methylation in splicing regulation. Trends Genet. 31, 274\u2013280 (2015).","journal-title":"Trends Genet."},{"key":"1322_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-022-08992-w","volume":"23","author":"S Lin","year":"2022","unstructured":"Lin, S., Yi, S. & Qiu, P. Comprehensive analysis of TCGA data reveals correlation between DNA methylation and alternative splicing. BMC Genom. 23, 758 (2022).","journal-title":"BMC Genom."},{"key":"1322_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13072-018-0205-1","volume":"11","author":"D Anastasiadi","year":"2018","unstructured":"Anastasiadi, D., Esteve-Codina, A. & Piferrer, F. Consistent inverse correlation between DNA methylation of the first intron and gene expression across tissues and species. Epigenetics Chromatin 11, 37 (2018).","journal-title":"Epigenetics Chromatin"},{"key":"1322_CR50","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/nsmb.2372","volume":"19","author":"T Khare","year":"2012","unstructured":"Khare, T. et al. 5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary. Nat. Struct. Mol. Biol. 19, 1037\u20131043 (2012).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1322_CR51","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fgene.2017.00100","volume":"8","author":"DQ Shi","year":"2017","unstructured":"Shi, D. Q., Ali, I., Tang, J. & Yang, W. C. New insights into 5hmC DNA modification: generation, distribution and function. Front Genet 8, 100 (2017).","journal-title":"Front Genet"},{"key":"1322_CR52","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2217\/epi-2016-0020","volume":"8","author":"A Madrid","year":"2016","unstructured":"Madrid, A., Papale, L. A. & Alisch, R. S. New hope: the emerging role of 5-hydroxymethylcytosine in mental health and disease. Epigenomics 8, 981\u2013991 (2016).","journal-title":"Epigenomics"},{"key":"1322_CR53","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s10048-015-0449-x","volume":"16","author":"V La Cognata","year":"2015","unstructured":"La Cognata, V., D\u2019Agata, V., Cavalcanti, F. & Cavallaro, S. Splicing: is there an alternative contribution to Parkinson\u2019s disease? Neurogenetics 16, 245\u2013263 (2015).","journal-title":"Neurogenetics"},{"key":"1322_CR54","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41588-022-01252-3","volume":"55","author":"F Wu","year":"2023","unstructured":"Wu, F. et al. Spurious transcription causing innate immune responses is prevented by 5-hydroxymethylcytosine. Nat. Genet. 55, 100\u2013111 (2023).","journal-title":"Nat. Genet."},{"key":"1322_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-670","volume":"15","author":"I Choi","year":"2014","unstructured":"Choi, I., Kim, R., Lim, H. W., Kaestner, K. H. & Won, K. J. 5-hydroxymethylcytosine represses the activity of enhancers in embryonic stem cells: a new epigenetic signature for gene regulation. BMC Genom. 15, 670 (2014).","journal-title":"BMC Genom."},{"key":"1322_CR56","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1039\/D3CS00858D","volume":"53","author":"E Kriukiene","year":"2024","unstructured":"Kriukiene, E., Tomkuviene, M. & Klimasauskas, S. 5-Hydroxymethylcytosine: the many faces of the sixth base of mammalian DNA. Chem. Soc. Rev. 53, 2264\u20132283 (2024).","journal-title":"Chem. Soc. Rev."},{"key":"1322_CR57","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"O Hansson","year":"2021","unstructured":"Hansson, O. Biomarkers for neurodegenerative diseases. Nat. Med. 27, 954\u2013963 (2021).","journal-title":"Nat. Med."},{"key":"1322_CR58","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/nn.2959","volume":"14","author":"KE Szulwach","year":"2011","unstructured":"Szulwach, K. E. et al. 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat. Neurosci. 14, 1607\u20131616 (2011).","journal-title":"Nat. Neurosci."},{"key":"1322_CR59","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.parkreldis.2019.07.032","volume":"66","author":"A Puschmann","year":"2019","unstructured":"Puschmann, A. et al. Low prevalence of known pathogenic mutations in dominant PD genes: A Swedish multicenter study. Parkinsonism Relat. Disord. 66, 158\u2013165 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1322_CR60","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1093\/bioinformatics\/btw527","volume":"32","author":"Z Xu","year":"2016","unstructured":"Xu, Z., Taylor, J. A., Leung, Y. K., Ho, S. M. & Niu, L. oxBS-MLE: an efficient method to estimate 5-methylcytosine and 5-hydroxymethylcytosine in paired bisulfite and oxidative bisulfite treated DNA. Bioinformatics 32, 3667\u20133669 (2016).","journal-title":"Bioinformatics"},{"key":"1322_CR61","doi-asserted-by":"crossref","unstructured":"Kolberg, L., Raudvere, U., Kuzmin, I., Vilo, J. & Peterson, H. gprofiler2\u2014an R package for gene list functional enrichment analysis and namespace conversion toolset g:Profiler. F1000Res 9, 709 (2020).","DOI":"10.12688\/f1000research.24956.2"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01322-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01322-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01322-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:02:57Z","timestamp":1775192577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01322-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1322"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01322-x","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this article, there were formatting errors in the figure captions. In Figure 1, the wording should read \u2018maximum values\u2019 instead of \u2018max-imumvalues\u2019. In Figure 3c, the correct wording should read \u2018represents intronic\u2019 instead of \u2018representsintronic\u2019, and \u2018represents exonic\u2019 instead of \u2018representsexonic\u2019. The original article has been updated accordingly.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}